Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 18 (RN7SKP18) is a non-coding RNA pseudogene related to the functional 7SK small nuclear RNA gene (RN7SK)[2]. As a pseudogene, it does not produce a functional RNA molecule or protein product and is not known to have any therapeutic or pharmacological relevance. It may be detected in genomic annotations as part of the extensive pseudogene family of 7SK, but there is no evidence that RN7SKP18 itself has a defined molecular or biological function, is involved in disease processes, or serves as a clinically actionable target[2].\n\nKey Points:\n- This entity is not a receptor, enzyme, transporter, or other therapeutic target—nor does it have known roles in signaling, cell cycle, or drug interactions[2].\n- The functional gene, RN7SK, encodes a small nuclear RNA involved in transcriptional regulation and innate immunity but is distinct from the pseudogene RN7SKP18[1][4].\n- No drugs, biomarkers, or disease associations have been reported for RN7SKP18.\n- There is no evidence for clinical, diagnostic, or safety concerns related to this pseudogene.\n\nIn summary, RN7SKP18 ("RN7SK pseudogene 18") is a human RNA pseudogene and is not considered a functional or therapeutic target[2]. If the intended query was for the functional RNA (RN7SK), refer to information on small nuclear RNA 7SK, which is involved in the regulation of transcriptional elongation and innate immune polarization but is distinct from RN7SKP18[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 18 (RN7SKP18).